RXMD 2019 3rd Quarterly Conference Call

Progressive Care, Inc. (RXMD)

“Progressive Care has developed significantly in a few short months,” stated S. Parikh Mars, CEO. “We are evolving in our space and creating the pathways to the next stage in our development. I am looking forward to discussing the results of the 3rd quarter, with eagle-eyed focus on the progress we have made toward the goals most important to our shareholders and where we are headed as we close out the year.”

Progressive Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 11-14-19 for 30 days of service.

Link to full disclosure about compensation paid to SmallCapVoice.com by companies featured on our website or in our e-mail communications.

Scroll to Top